The study, led by Dr. Keisuke Obara, Dr. Kento Yoshioka, and Professor Yoshio Tanaka of the Faculty of Pharmaceutical Sciences, found that ferulic acid (FA) can reduce intestinal smooth muscle contractions by blocking voltage-dependent calcium channels. The discovery could eventually support new dietary approaches for intestinal motility disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).

A Common Compound in Whole Grains

Ferulic acid is a polyphenol found in many plant-based foods, especially whole grains and rice bran. It is already known for its antioxidant and neuroprotective effects, and previous research has largely examined how it may benefit the body more broadly.

Much less was known, however, about its effects on gastrointestinal motility, the coordinated muscle activity that moves food and waste through the digestive system.

People with IBS and IBD can experience abnormal intestinal movement. In some cases, the gut contracts too much, while in others, movement is reduced. The researchers set out to determine whether FA could directly alter these contractions.

Ferulic Acid Reduced Intestinal Contractions

The team tested FA using guinea pig ileal longitudinal smooth muscle (ILSM). The compound significantly reduced contractions triggered by several signaling molecules, including acetylcholine, histamine, prostaglandin F_2α, and serotonin.

The inhibitory effect was reversible, meaning normal contractions returned after FA was removed. It was also concentration-dependent, with stronger effects appearing at higher concentrations.

The researchers found that FA acted in a noncompetitive manner. This suggests that it did not simply block the receptors used by the signaling molecules. Instead, it appeared to interfere with a shared mechanism involved in muscle contraction.

Blocking Calcium Signals in Smooth Muscle

Additional experiments using vascular smooth muscle cell models offered a possible explanation. FA reduced the rise in intracellular calcium caused by potassium chloride.

Calcium entering smooth muscle cells plays a central role in triggering contraction. The results indicate that FA suppresses this process by inhibiting voltage-dependent calcium channels, reducing the calcium signals needed for the muscles to tighten.

Possible Benefits and Risks for Gut Disorders

The findings suggest that FA may act as a natural regulator of intestinal motility. By calming excessive smooth muscle activity, it could potentially help people with diarrhea-predominant IBD.

The same effect may not be beneficial for everyone. In people with constipation-predominant IBS, or in healthy individuals, further slowing intestinal movement could make constipation or related symptoms worse.

Human Studies Are Still Needed

The researchers emphasized that the concentrations of FA that produced an effect in vitro were higher than the blood levels usually reached through normal dietary intake.

However, FA concentrations inside the intestines may be higher after food or supplements are consumed because the compound comes into direct contact with the digestive tract. More research will be needed to determine whether the laboratory findings reflect what happens in the human body.

The study provides a foundation for investigating whether ferulic acid could eventually be used in dietary interventions or supplements designed to regulate gut movement. Clinical trials will be necessary to confirm its effects in people, identify which patients might benefit, and determine safe and effective intake levels.